Related Experiment Video
Updated: May 26, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Editorial update on emerging drugs for cancer cachexia
Expert Opinion on Emerging Drugs
|January 11, 2012
Summary
Cancer cachexia causes muscle wasting and weakness in advanced cancer patients, leading to reduced quality of life and increased mortality. Effective treatment likely involves combining new drugs with exercise training.
Area of Science:
- Oncology
- Metabolism
- Gerontology
Background:
- Cancer cachexia is a complex syndrome causing significant muscle loss and weakness in advanced cancer patients.
- This condition profoundly impacts patient quality of life and contributes to over 20% of cancer-related deaths.
- Current research is exploring various therapeutic avenues, including appetite stimulants, anti-inflammatory agents, and catabolism inhibitors.
Discussion:
- The multifactorial nature of cancer cachexia suggests that combination therapies will be most effective.
- Integrating pharmacological interventions with exercise training is crucial for maximizing treatment efficacy.
- Addressing both the underlying pathology and the physical decline is essential for comprehensive patient care.
Key Insights:
- Cancer cachexia is a major cause of mortality and morbidity in advanced cancer.
- Novel drug therapies targeting appetite, inflammation, and catabolism are under development.
- Combined therapeutic strategies, including drug combinations and exercise, show promise for improved outcomes.
Outlook:
- Future research should focus on optimizing combination drug regimens for cancer cachexia.
- Clinical trials investigating the synergistic effects of exercise and pharmacotherapy are warranted.
- The ultimate goal is to improve survival rates and enhance the quality of life for cancer patients experiencing cachexia.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...